Target intelligence / Profile preview

Diphthamide biosynthesis protein 3 (DPH3)

Target
DPH3
Molecular classification
Other (electron carrier protein, CSL-type zinc finger family)
01

Overview

Diphthamide biosynthesis protein 3 (DPH3) is a small, CSL-type zinc finger-containing protein essential for the post-translational modification of elongation factor 2 (eEF2) at a specific histidine residue, resulting in the diphthamide group—this modification is the target for ADP-ribosylation by bacterial toxins such as diphtheria toxin and Pseudomonas exotoxin A, which inactivates eEF2 and halts protein synthesis. DPH3 acts as an electron donor, transferring electrons to and helping maintain the [4Fe–4S] clusters in the DPH1–DPH2 enzyme complex, enabling the critical first step of diphthamide biosynthesis. DPH3 also participates in tRNA modifications via interaction with the elongator complex, and may play broader roles in cellular processes including transcription regulation and endocytosis, though these are less well characterized. DPH3 is not itself considered a direct therapeutic target, but its function is crucial for the sensitivity of cells to certain bacterial toxins.

Other names
DESR1ZCSL2DelGIP1DELGIP1MGC20197KTI11DELGIPDPH3ACSL-type zinc finger-containing protein 2DelGEF-interacting protein 1KTI11 homolog A (S. cerevisiae)DPH3 homolog (KTI11, S. cerevisiae)KTI11 homologDel-GEF interacting proteindeafness locus putative guanine nucleotide exchange factor interacting protein 1diphtheria toxin and Pseudomonas exotoxin A sensitivity required gene 1zinc finger, CSL domain containing 2
02

Mechanism of action

Not applicable (DPH3 itself is not targeted by therapeutics; rather, its function is essential for post-translational modification of elongation factor 2, which is the target for diphtheria toxin and Pseudomonas exotoxin A)

03

Biological functions

Diphthamide biosynthesis (modification of elongation factor 2)Electron transfer to iron-sulfur (Fe-S) cluster enzymesInvolvement in tRNA wobble base modifications (via the elongator complex)Possible functions in transcription regulation, endocytosis, and secretion
04

Disease associations

Infection (related to diphtheria toxin and Pseudomonas exotoxin A sensitivity)Other (some studies mention associations with melanoacanthoma and diphtheria; no major direct evidence for other diseases at this time)
05

Safety considerations

None specifically established for direct targeting; loss of function would be predicted to disrupt protein synthesis and cell viability

Beyond the preview

Go deeper on Diphthamide biosynthesis protein 3 (DPH3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diphthamide biosynthesis protein 3 (DPH3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call